MICHAEL D DUPRE
Allopathic & Osteopathic Physicians|Family Medicine PELL CITY, AL NPI 1104802495
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine AL ABBVIE INC. All categories
General Payments — all program years on this page
$10,735.24
- Category: General Payments
- Program years: PY2018–2024
- Record count: 655
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,927.40 across 121 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,927.40 | 121 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $375.02 | 35 |
| PFIZER INC. | $222.94 | 15 |
| Novo Nordisk AS | $219.30 | 16 |
| Amgen Inc. | $213.30 | 11 |
| Lilly USA, LLC | $139.72 | 8 |
| Neurocrine BioSciences, Inc. | $98.23 | 3 |
| Sumitomo Pharma America, Inc. | $90.57 | 4 |
| Ardelyx, Inc. | $89.27 | 4 |
| Antares Pharma, Inc. | $76.59 | 3 |
| Acerta Pharma LLC | $55.51 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.86 | 3 |
| GlaxoSmithKline, LLC. | $41.67 | 2 |
| Corium, Inc. | $38.53 | 3 |
| Astellas Pharma US Inc | $34.55 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $34.41 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $33.59 | 2 |
| Phathom Pharmaceuticals, Inc. | $30.87 | 1 |
| Atland Pharmaceuticals, LLC | $30.25 | 1 |
| SHIELD THERAPEUTICS INC | $19.14 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.41 | 1 |
| Exact Sciences Corporation | $15.67 | 1 |
By program year
Records — PY2024 (121)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.